Barrier Functions oF Skin in ICU: SKIN-BAR (SKIN-BAR)
Investigation of Skin Barrier Function Using Biosensor Methods in Risky Skin Regions and Developed Pressure Injuries in Intensive Care Patients, and Identification of Influencing Factors: The SKIN-BAR Project
研究概览
地位
详细说明
Pressure injuries (PIs) remain a major complication in intensive care units (ICUs), associated with increased morbidity, mortality, and healthcare costs. Early detection and prevention are critical; however, current assessment methods rely largely on subjective clinical evaluation and risk scales, which may lack sensitivity in detecting subclinical skin barrier impairment.
Recent advances in biosensor technology enable objective, non-invasive assessment of skin barrier function through biophysical parameters such as transepidermal water loss (TEWL), skin pH, stratum corneum hydration, local temperature, and sebum levels. These parameters reflect epidermal integrity and may provide early indicators of pressure-induced tissue damage before visible clinical signs emerge.
The SKIN-BAR study is designed as a prospective, longitudinal cohort study conducted in ICU patients. The primary objective is to evaluate skin barrier function in pressure injury-prone anatomical regions and to identify factors influencing these parameters. Specifically, the study aims to:
- assess temporal changes in biophysical skin parameters,
- examine relationships between these parameters,
- compare measurements between pressure injury-developing and non-developing patients, and
- identify clinical and demographic factors associated with impaired skin barrier function.
Data will be collected using validated, non-invasive biosensor devices. Measurements will be performed at multiple time points (including early ICU admission and follow-up intervals) and across multiple anatomical sites, including the sacrum, trochanters, scapulae, lateral legs, and posterior neck. Control measurements from adjacent intact skin will also be obtained.
A comprehensive dataset including clinical, demographic, and physiological variables will be analyzed to determine predictors of pressure injury development and to better understand the pathophysiological mechanisms underlying skin barrier disruption in critically ill patients.
This study is expected to contribute to the development of objective, evidence-based approaches for early detection and prevention of pressure injuries in ICU settings and to support the integration of biosensor technologies into clinical care protocols.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:TUĞBA ERDEM, PhD
- 电话号码:+90 532 739 15 01
- 邮箱:tyeni@ku.edu.tr
学习地点
-
-
-
Istanbul、土耳其(türkiye)、34000
- Koc University
-
接触:
- TUĞBA ERDEM, PhD
- 电话号码:+90 532 739 1501
- 邮箱:tyeni@ku.edu.tr
-
接触:
- Meryem YILDIZ AYVAZ, PhD
- 电话号码:+90 554 379 8373
- 邮箱:mayvaz@ku.edu.tr
-
副研究员:
- EVREN ŞENTÜRK, PROFESSOR
-
副研究员:
- EREN AÇIK, Medical Doctor
-
副研究员:
- ŞÜKRAN GURA, MSc Nurse
-
副研究员:
- MERYEM YILDIZ AYVAZ, PhD
-
首席研究员:
- TUĞBA ERDEM, PhD
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
描述
Inclusion Criteria:
- Adults aged >18 years
- Admission to the intensive care unit
- Initial skin assessment completed within the first 4 hours after ICU admission
- Hemodynamically stable enough to undergo follow-up and repeated skin measurements
- Intact skin integrity at ICU admission
- Willingness to participate in the study, with informed consent provided by the participant or legally authorized representative
Exclusion Criteria:
- Inability to tolerate position changes
- Post-cardiopulmonary resuscitation care period at enrollment
- Cardiac arrest or cardiopulmonary resuscitation during follow-up
- Severe edema or subcutaneous fluid accumulation
- Presence of skin lesions before ICU admission
- Systemic dermatologic disease directly affecting skin barrier function
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
Cohort 1: Patients Without Pressure Injury
ICU patients who do not develop pressure injuries during the follow-up period.
Skin barrier function parameters (TEWL, pH, stratum corneum hydration, local skin temperature) will be measured longitudinally in pressure injury-prone anatomical regions.
|
|
Cohort 2: Patients With Pressure Injury
ICU patients who develop pressure injuries during the follow-up period.
Skin barrier function parameters will be assessed in both pressure injury-prone regions and adjacent intact skin areas to evaluate changes associated with pressure injury development.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in transepidermal water loss (TEWL) in pressure injury-prone anatomical regions
大体时间:From ICU admission (within the first 4 hours), 24 hours, 48 hours, 96 hours, day 13.
|
Transepidermal water loss (TEWL) values measured using a non-invasive biosensor device in pressure injury-prone anatomical regions, including the sacrum, right and left trochanters, right and left lateral legs, right and left scapulae, and posterior neck.
TEWL will be evaluated longitudinally to determine temporal changes in skin barrier function and its association with pressure injury development.
|
From ICU admission (within the first 4 hours), 24 hours, 48 hours, 96 hours, day 13.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in skin surface pH in pressure injury-prone anatomical regions
大体时间:From ICU admission (within the first 4 hours), 24 hours, 48 hours, 96 hours, day 13.
|
Skin surface pH values measured longitudinally in pressure injury-prone anatomical regions using a non-invasive pH meter to assess changes in skin barrier acidity over time.
|
From ICU admission (within the first 4 hours), 24 hours, 48 hours, 96 hours, day 13.
|
|
Change in local skin temperature in pressure injury-prone anatomical regions
大体时间:From ICU admission (within the first 4 hours), 24 hours, 48 hours, 96 hours, day 13.
|
Local skin temperature measured in pressure injury-prone anatomical regions as a biophysical indicator of tissue stress and early skin barrier alteration.
|
From ICU admission (within the first 4 hours), 24 hours, 48 hours, 96 hours, day 13.
|
|
Incidence of pressure injury during ICU stay
大体时间:Daily from baseline through Day 13 (or until ICU discharge, whichever occurs first)
|
Occurrence of new pressure injuries during ICU stay, assessed according to international pressure injury classification criteria.
|
Daily from baseline through Day 13 (or until ICU discharge, whichever occurs first)
|
合作者和调查者
出版物和有用的链接
一般刊物
- McEvoy NL, Patton D, Curley GF, Moore Z. Pressure ulcer risk assessment in the ICU. Is it time for a more objective measure? Intensive Crit Care Nurs. 2024 Aug;83:103681. doi: 10.1016/j.iccn.2024.103681. Epub 2024 Mar 21.
- Abiakam NS, Jayabal H, Filingeri D, Bader DL, Worsley PR. Spatial and temporal changes in biophysical skin parameters over a category I pressure ulcer. Int Wound J. 2023 Oct;20(8):3164-3176. doi: 10.1111/iwj.14194. Epub 2023 Apr 14.
- Bader DL, Worsley PR. Technologies to monitor the health of loaded skin tissues. Biomed Eng Online. 2018 Apr 12;17(1):40. doi: 10.1186/s12938-018-0470-z.
- Akdeniz M, Gabriel S, Lichterfeld-Kottner A, Blume-Peytavi U, Kottner J. Transepidermal water loss in healthy adults: a systematic review and meta-analysis update. Br J Dermatol. 2018 Nov;179(5):1049-1055. doi: 10.1111/bjd.17025. Epub 2018 Sep 9.
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 425S012
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.